Technology | 2019.10.17
ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tau
Data show antibody candidates bind toxic forms of tau and inhibit its propagation in a cellular model TORONTO and CAMBRIDGE, MA, Oct. 17, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ic-forms-of-tau-300940141.html
